LESLIE JACKSON: Open Payments
NPI 1144906355 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 30 payments from 14 companies in 2025. Trend: 2023 $127 · 2024 $348 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $192 |
| Corcept Therapeutics | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Lundbeck LLC | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| Kedrion Biopharma, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: QULIPTA, Korlym, UBRELVY, Kerendia, JARDIANCE, REXULTI, VRAYLAR, XIFAXAN.
Industry payments across TX — which companies pay providers there.
